3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tuberculosis
1
Thoracic Cancer
1
Shwachman-Diamond Syndrome
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Precancerous Conditions
1
Pneumonia
1
Pathologic Complete Response
1
Pancreatic Intraductal Neoplasms
1
Osteosarcoma
1
Osteoporosis
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Interventions
Fluorouracil
2
Docetaxel
2
thymoglobulin
1
temsirolimus
1
sargramostim
1
pirarubicin
1
pembrolizumab
1
pazopanib
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
X-Rays
1
Whole-Body Irradiation
1
Trastuzumab
1
Tacrolimus
1
Surveys and Questionnaires
1
Rituximab
1
Radiotherapy
1
Proctectomy
1
Pemetrexed
1
Oxaliplatin
1
Mycophenolic Acid
1
Monatide (IMS 3015)
1
Metformin
1
Melphalan
1
Leucovorin
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Epirubicin
1
Drug Therapy
1
Diphenhydramine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pathologic Complete Response
×
X-Rays
×
Clear all
NCT02233374
2022-10-28
PRISM
Royal North Shore Hospital
Phase NA
Completed
27 enrolled